Burzynski Research Institute, Inc.
|
-0.01 USD
|
-3723.529%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
82.819%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
103.768%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-2810.448%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-1114.953%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
106.555%
|
Qrons Inc.
|
-0.06 USD
|
-568.954%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-25900.0%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-578.261%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-3800.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
92.737%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.232%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-657.282%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
85.87%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-346.224%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-1545.57%
|
Mesoblast Limited
|
-0.09 USD
|
-337.71%
|
Marizyme, Inc.
|
-1.44 USD
|
72.917%
|
Genus plc
|
0.12 USD
|
425.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
83.262%
|
Pharming Group N.V.
|
-0.02 USD
|
-2322.36%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-55614.286%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
7.143%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-304.145%
|
ContraFect Corporation
|
-124.97 USD
|
99.688%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-828.571%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-3150.0%
|
IMV Inc.
|
-4.37 USD
|
91.076%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-1001.695%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-389900.0%
|
ONE Bio Corp.
|
1.43 USD
|
127.273%
|
Accustem Sciences Inc.
|
-0.34 USD
|
-14.706%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
32.759%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-225.0%
|
Q BioMed Inc.
|
-0.08 USD
|
-399.36%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-454.765%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
-18.182%
|
Biomind Labs Inc.
|
-0.02 USD
|
-2307.407%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.95%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-5170.27%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-1859.799%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-16150.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-48650.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-50.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-4331.818%
|
GB Sciences, Inc.
|
-0.00 USD
|
-9412.195%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-160.0%
|
HST Global, Inc.
|
-0.03 USD
|
-1297.849%
|
CSL Limited
|
2.73 USD
|
114.286%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-678.443%
|
Halberd Corporation
|
-0.00 USD
|
-389900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-55614.286%
|
Agentix Corp.
|
-0.04 USD
|
-1014.286%
|
Resverlogix Corp.
|
-0.01 USD
|
-2646.479%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-417.241%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
92.442%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
30100.0%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
1653.785%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-992.437%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-1850.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-623.562%
|
Zenith Capital Corp.
|
-0.07 USD
|
-457.94%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-759.031%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-6090.476%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
89.655%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-77900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-327.163%
|
Kadimastem Ltd
|
-0.78 USD
|
50.0%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
91.702%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
98.928%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
37.097%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-3177.311%
|
LadRx Corporation
|
0.68 USD
|
157.353%
|
Cell Source, Inc.
|
-0.17 USD
|
-129.412%
|
Regen BioPharma, Inc.
|
0.29 USD
|
234.483%
|
Regen BioPharma, Inc.
|
0.26 USD
|
250.0%
|
NovAccess Global Inc.
|
-0.23 USD
|
-69.565%
|
Itoco Inc.
|
-0.01 USD
|
-5031.579%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-3800.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-15500.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-6864.286%
|
CytoDyn Inc.
|
-0.05 USD
|
-637.24%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-77900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-1656.757%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.746%
|
SYBLEU INC
|
-0.02 USD
|
-2128.571%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-2646.479%
|
International Stem Cell Corporation
|
-0.02 USD
|
-2278.049%
|
Bioxytran, Inc.
|
-0.03 USD
|
-1122.571%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-389900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
95.119%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
66.949%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-1047.059%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-6090.476%
|
Neutra Corp.
|
-0.00 USD
|
-389900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.586%
|
PureTech Health plc
|
-2.38 USD
|
83.613%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
53.012%
|
IXICO plc
|
-0.02 USD
|
-1498.361%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-586.62%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
71.111%
|
CSL Limited
|
5.47 USD
|
107.13%
|
Cellectis S.A.
|
-1.77 USD
|
77.966%
|